Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

The condition is better measured by looking at factors like inflammation, insulin resistance, and glucose tolerance, ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes, according to a study published online Jan. 21 in JAMA Network ...

The team categorized pediatric obesity treatment response, based on changes in body mass index standard deviation score, as ...

An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

Obesity, long determined by the flawed metric of BMI, should be diagnosed based on other measurements, experts argue.

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Obesity and type 2 diabetes are closely linked. Excess body fat can alter your body’s metabolic system, promote insulin resistance, and trigger inflammatory responses that affect how well your ...

A global group of experts has suggested a new approach to diagnosing and treating obesity that does not rely solely on the ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...